56PDAnalytic validation of tumor mutational burden as a companion diagnostic for combination immunotherapy in non-small cell lung cancer. (23rd October 2018) - Fabrizio, D A; Milbury, C; Yip, W-K; Ramamurthy, L; Bai, X; Pattani, V; Maness, P; Cowen, A; Fedorchak, K; Ma, P; Frampton, G M; Connelly, C; et al.